EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Eurobio Scientific's enterprise value is €159.9 Mil.
Eurobio Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €130.6 Mil. Therefore, Eurobio Scientific's EV-to-Revenue for today is 1.22.
The historical rank and industry rank for Eurobio Scientific's EV-to-Revenue or its related term are showing as below:
XPAR:ALERS'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.48 Med: 1.01 Max: 4.22
Current: 1.23
During the past 13 years, the highest EV-to-Revenue of Eurobio Scientific was 4.22. The lowest was 0.48. And the median was 1.01.
XPAR:ALERS's EV-to-Revenue is ranked better than 80.1% of 829
companies
in the Medical Devices & Instruments industry
Industry Median: 3.27
vs XPAR:ALERS: 1.23
The historical data trend for Eurobio Scientific's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eurobio Scientific's EV-to-Revenue
For the Medical Devices subindustry, Eurobio Scientific's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurobio Scientific's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Eurobio Scientific's EV-to-Revenue falls into.
Eurobio Scientific's current Enterprise Value is €159.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurobio Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €130.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurobio Scientific's share price for today is €14.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €12.91.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurobio Scientific EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Eurobio Scientific's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Eurobio Scientific (XPAR:ALERS) Business Description
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:ALERS has been successfully added to your 